Specialtycare IOM Services, LLC v. Medsurant Holdings, LLC

CourtCourt of Appeals of Tennessee
DecidedJuly 6, 2018
DocketM2017-00309-COA-R3-CV
StatusPublished

This text of Specialtycare IOM Services, LLC v. Medsurant Holdings, LLC (Specialtycare IOM Services, LLC v. Medsurant Holdings, LLC) is published on Counsel Stack Legal Research, covering Court of Appeals of Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Specialtycare IOM Services, LLC v. Medsurant Holdings, LLC, (Tenn. Ct. App. 2018).

Opinion

07/06/2018 IN THE COURT OF APPEALS OF TENNESSEE AT NASHVILLE March 28, 2018 Session

SPECIALTYCARE IOM SERVICES, LLC v. MEDSURANT HOLDINGS, LLC, ET AL.

Appeal from the Chancery Court for Davidson County No. 15-695-II Carol L. McCoy, Chancellor ___________________________________

No. M2017-00309-COA-R3-CV ___________________________________

Appellant appeals the trial court’s entry of default judgment as a discovery sanction against it. Because there is insufficient evidence of contumacious conduct on the part of Appellant to justify default, we reverse the trial court’s entry of default judgment on liability. We vacate the trial court’s award of damages on the jury verdict, but affirm the award of attorney’s fees as an initial discovery sanction.

Tenn. R. App. P. 3 Appeal as of Right; Judgment of the Chancery Court Reversed in Part, Vacated in Part, Affirmed in Part and Remanded

KENNY ARMSTRONG, J., delivered the opinion of the court, in which W. NEAL MCBRAYER and ARNOLD B. GOLDIN, JJ., joined.

W. Brantley Phillips, Jr., Russell E. Stair, Matthew J. Sinback, Robert J. Mendes, and R. Mark Donnell, Jr., Nashville, Tennessee, for the appellants, Medsurant Holdings, LLC, and Medsurant, LLC.

Thor Y. Urness, Patricia Head Moskal, and R. Brandon Bundren, Nashville, Tennessee, for the appellee, SpecialtyCare IOM Services, LLC.

OPINION

I. Background

SpecialtyCare IOM Services, LLC (“SpecialtyCare,” or “Appellee”) and Medsurant Holdings, LLC (“Holdings”) and Medsurant, LLC (together with Holdings, “Medsurant,” or “Appellants”) are direct competitors in the intraoperative neurophysiologic monitoring services (“IOM”) industry. IOM services are typically used for patients undergoing operations related to the nervous system, or procedures that pose a risk to nervous system integrity, e.g., spinal surgery, certain brain surgeries, carotid endarterectomy, etc. During such surgeries, a trained IOM clinician, who is employed by an IOM company, attaches a computer system to the patient using electrodes, and interactive software then performs two primary tasks: (1) a selective activation of stimulating electrodes; and (2) processing and displaying electrophysiologic signals from the electrodes. This procedure allows physicians to observe and document electrophysiologic signals in real time either in the operating room or remotely. Customers of IOM companies include health care systems, acute care hospitals, and surgery centers. IOM services are quite specialized, and physicians and clinicians work side-by-side. Accordingly, the success of an IOM company significantly depends on the clinicians developing and maintaining close business relationships with the customers. The IOM industry is comprised of only a few IOM companies. SpecialtyCare is the largest IOM provider, and IOM services account for approximately 30% of its business. Medsurant is significantly smaller than SpecialtyCare, and Medsurant and SpecialtyCare vigorously compete for IOM business in the market.

In January 2015, both Medsurant and SpecialtyCare bid to buy another IOM company, ProNerve, which was in bankruptcy. After executing confidentiality agreements, SpecialtyCare and Medsurant obtained conditional access to ProNerve’s confidential and competitive information, including information about its employees and customers. SpecialtyCare was the successful bidder at approximately $11 million. On February 24, 2015, SpecialtyCare and ProNerve executed an Asset Purchase Agreement (“APA”), which was approved by the U.S. Bankruptcy Court for the District of Delaware on April 10, 2015.

After executing the APA but before the bankruptcy court approved the sale, SpecialtyCare sent letters to ProNerve employees, advising them of the acquisition and offering them positions with SpecialtyCare (contingent on the approval of the sale in bankruptcy court). Ultimately, 91 ProNerve IOM technicians accepted positions with SpecialtyCare, and 23 ProNerve technicians obtained employment elsewhere. Nine ProNerve employees took positions with Medsurant. Each of these former employees had one or more restrictive covenant agreements with ProNerve.

On June 10, 2015, SpecialtyCare filed suit against Holdings and Medsurant, alleging four business tort claims: (1) Medsurant intentionally and maliciously induced ProNerve employees and customers to violate or breach the terms of their contracts that SpecialtyCare acquired, i.e., procurement of breach of contract (Counts I and II); and (2) Medsurant intentionally and wrongfully interfered with existing employee and customer relationships or, alternatively, with prospective business relationships with those employees and customers, i.e., tortious interference with business relationships (Counts III and IV). On November 12, 2015, SpecialtyCare filed its first amended complaint; on -2- December 30, 2015, SpecialtyCare filed a second amended complaint. Medsurant answered all of the complaints, denying any liability.

As discussed in detail below, Medsurant allegedly refused to cooperate in discovery. Accordingly, SpecialtyCare filed a motion to compel discovery, and after a hearing, the trial court entered an order on November 4, 2015, see infra. When Medsurant allegedly failed to comply with the November 4, 2015 order, SpecialtyCare moved for discovery sanctions. The trial court convened several hearings on sanctions. While these sanction hearings were ongoing, on January 21, 2016, Medsurant’s attorney moved for withdrawal, and attorneys with Bryan Cave, LLC and Harwell, Howard, Hyne, Gabbert, & Manner, P.C. were substituted as counsel of record. SpecialtyCare did not contest the motion allegedly on Medsurant’s assurance that substitution of new counsel would not cause further delays.

Following the second hearing on sanctions, the trial court imposed an initial discovery sanction, ordering Medsurant to pay SpecialtyCare’s attorney’s fees and costs incurred by discovery delays. At a third hearing, the trial court verbally warned Medsurant that it risked default judgment if it continued to abuse the discovery process. Finally, after a fourth sanction hearing, the trial court entered an order of default against Medsurant on May 3, 2016. Medsurant moved to set aside the default judgment. The trial court heard the motion on August 5 and August 12, 2016.

On August 15, 2016, the trial court entered an order on the attorney’s fee sanctions, wherein it awarded SpecialtyCare $119,815.77 in attorney’s fees and costs. On August 24, 2016, the trial court entered an order denying Medsurant’s motion to set aside the default judgment on liability.

On August 22 through August 26, 2016, the case proceeded to the jury on the issue of damages. Compensatory damages and punitive damages were bifurcated. Following the compensatory damage phase, the jury returned a verdict of $2.8 million in favor of SpecialtyCare. Following the punitive damages phase, the jury returned a verdict of $16 million, finding that Medsurant had intentionally destroyed material evidence for the purpose of evading liability, thus supporting removal of the statutory cap. Following its Hodges v. S.C. Toof & Co., 833 S.W.2d 896 (Tenn. 1992) review, the trial court affirmed the damages award and entered its final judgment on September 20, 2016. In addition to affirming the jury verdict on damages, the September 20, 2016 order also affirms the trial court’s previous award of $119,815.77 in attorney’s fees as a discovery sanction. The trial court denied Medsurant’s post-trial motions to alter or amend or for a new trial by orders entered on January 18, 2017. Medsurant appeals. II. Issues

Mesurant raises five issues as stated in its brief:

-3- 1.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Steppach v. Thomas
346 S.W.3d 488 (Court of Appeals of Tennessee, 2011)
Pegues v. Illinois Central Railroad
288 S.W.3d 350 (Court of Appeals of Tennessee, 2008)
Mercer v. Vanderbilt University, Inc.
134 S.W.3d 121 (Tennessee Supreme Court, 2004)
Eldridge v. Eldridge
42 S.W.3d 82 (Tennessee Supreme Court, 2001)
Potts v. Mayforth
59 S.W.3d 167 (Court of Appeals of Tennessee, 2001)
Murray v. Christian Methodist Episcopal Church
153 S.W.3d 371 (Court of Appeals of Tennessee, 2004)
State v. Lewis
235 S.W.3d 136 (Tennessee Supreme Court, 2007)
Lyle v. Exxon Corp.
746 S.W.2d 694 (Tennessee Supreme Court, 1988)
In Re the Adoption of E.N.R.
42 S.W.3d 26 (Tennessee Supreme Court, 2001)
Manufacturers Consolidation Service, Inc. v. Rodell
42 S.W.3d 846 (Court of Appeals of Tennessee, 2000)
Shahrdar v. Global Housing, Inc.
983 S.W.2d 230 (Court of Appeals of Tennessee, 1998)
Bing v. Baptist Memorial Hospital-Union City
937 S.W.2d 922 (Court of Appeals of Tennessee, 1996)
March v. Levine
115 S.W.3d 892 (Court of Appeals of Tennessee, 2003)
Alexander v. Jackson Radiology Associates
156 S.W.3d 11 (Court of Appeals of Tennessee, 2004)
Hodges v. S.C. Toof & Co.
833 S.W.2d 896 (Tennessee Supreme Court, 1992)
Holt v. Webster
638 S.W.2d 391 (Court of Appeals of Tennessee, 1982)
Palmer v. Palmer
562 S.W.2d 833 (Court of Appeals of Tennessee, 1977)
Broadway Motor Co., Inc. v. Fire Insurance Co.
12 Tenn. App. 278 (Court of Appeals of Tennessee, 1930)

Cite This Page — Counsel Stack

Bluebook (online)
Specialtycare IOM Services, LLC v. Medsurant Holdings, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/specialtycare-iom-services-llc-v-medsurant-holdings-llc-tennctapp-2018.